Jan 15, 2020 / 11:00PM GMT
Tycho W. Peterson - JP Morgan Chase & Co, Research Division - Senior Analyst
Okay. We're going to go ahead and kick it off. I'm Tycho Peterson from the Life Science team. It's my pleasure to introduce our next company this afternoon, NanoString. Breakout will be right after in the Yorkshire room. And with that, I'm going to turn it over to Brad.
R. Bradley Gray - NanoString Technologies, Inc. - CEO, President & Director
Thank you, Tycho. I've been looking forward to this. NanoString has had a transformative 2019, and 2020 is going to be just as great a year. With the launch of our GeoMx Digital Spatial Profiler, our revenue is accelerating and redefining who we are as a company.
Today, I look forward to recapping some of our successes in 2019 and giving you a preview of 2020, but I thought it would be best to start with some breaking news. Earlier this morning, the journal Nature published 2 landmark papers, enabled by the GeoMx Digital Spatial Profiler. Both of them are in the important field of immuno-oncology, biomarker discovery and research
NanoString Technologies Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot